1-4 of 4
Peter J Hosein
Close
Save search
Sort by
Journal Articles

Phase II study of 90 y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Free
Jesus C Fabregas, MD, James E. Hoffman, MD, Tulay Koru-Sengul, PhD, Miao Feng, Deborah Goodman, Aldo Serafini, MD, Peter J Hosein, MD, Alexandra Stefanovic, MD, Joseph D. Rosenblatt, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2014) 124 (21): 1762.
https://doi.org/10.1182/blood.V124.21.1762.1762
Published: 2014
Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Free
Matthew P Salzberg, Jocelyn C Maragulia, Oliver W. Press, MD, PhD, Thomas M Habermann, MD, Julie M Vose, MD, MBA, Martin Bast, BS, Ranjana H. Advani, MD, Andrew M. Evens, DO, MSc, Nahida Islam, MD, John P. Leonard, MD, Peter Martin, MD, Peter J Hosein, MD, Andrew D Zelenetz, MD, PhD, Izidore S Lossos, MD
Journal: Blood
Blood (2012) 120 (21): 1618.
https://doi.org/10.1182/blood.V120.21.1618.1618
Published: 2012
Journal Articles

Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma

Free
Jose D Sandoval-Sus, MD, Peter J Hosein, MD, Deborah Goodman, BHSC, Alexandra Stefanovic, MD, Joseph D Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2012) 120 (21): 1622.
https://doi.org/10.1182/blood.V120.21.1622.1622
Published: 2012
Journal Articles

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Free
Peter J Hosein, MD, Daniel Morgensztern, MD, Francine Coleman, MPH, Gail Walker, PhD, Maricer Escalon, MD, Joseph Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2008) 112 (11): 3597.
https://doi.org/10.1182/blood.V112.11.3597.3597
Published: 2008